What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Research
NCT06656702 - Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
Clinical Trial in Baltimore, Maryland
This study aims to study the feasibility of psilocybin therapy for patients with Amyotropic Lateral Sclerosis (ALS) with depressed mood. The secondary objective is to assess its impact on depression, quality of life, hopelessness, and functional status in this patient population. Source record lists lead sponsor Johns Hopkins University and overall status Recruiting.
Clinical TrialResearch
Directory Facts
- Status
- Verified from official/source records
- Price
- Free study screening / research participation
- Hours
- Verify with provider
- License / Record
- NCT06656702
- Last Verified
- 2026-06-12
Location
Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore, Maryland
Source Notes
Discovery row generated from the official ClinicalTrials.gov API record for NCT06656702; status Recruiting; sponsor Johns Hopkins University.
Source: https://clinicaltrials.gov/study/NCT06656702
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.